Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Lancet (London, England)|March 30, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trialLauren C Tindale, Jason S Richardson, Deborah M Anderson, et al.
The Lancet. Infectious Diseases|June 16, 2022
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trialSean R Bennett, James M McCarty, Roshan Ramanathan, et al.
Lancet (London, England)|March 30, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trialJason S Richardson, Deborah M Anderson, Jason Mendy, et al.
NPJ Vaccines|January 6, 2026
Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremiaChristopher S Morello, Ravi Anantha, Jason E Comer, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
NPJ Vaccines|March 19, 2026
A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humansLark L Coffey, Katherine J Olstad, J Rachel Reader, et al.
Research Square|December 3, 2025
A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humansLark L Coffey, Katherine J Olstad, J Rachel Reader, et al.
Pageof 3